Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
Oechsner M, Korchounov A
Parkinsonklinik Bad Nauheim, Germany. m.oechsner@parkinsonzentrum.de
This is a report on a case series of five patients with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10-20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen.
Published 6 April 2005 in Hum Psychopharmacol, 20(3): 203-5.
Full-text of this article is available online (may require subscription).
© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.
| 
